BJ
TPST icon

BlackRock Japan’s Tempest Therapeutics TPST Stock Holding History

BlackRock Japan’s Portfolio TPST Stock Details TPST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Hold
0
– -$4K – 1310
2014
Q2 		– Hold
0
– – – 1246
2014
Q1 		– Hold
0
– -$1K – 1454
2013
Q4 		– Sell
-1
Closed -$27.4K – 1332
2013
Q3 		$24K Buy
+1
New +$35.5K ﹤0.01% 1214

Other funds holding TPST

DVC
Deer VII & Co Larchmont, New York $317M AUM 30.89% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
BCM
BBT Capital Management Fort Worth, Texas $85.5M AUM 11.09% 1-Year Est. Return
TS
Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return

BlackRock Japan's TPST Position: Q3 2014 in Review

BlackRock Japan held its Tempest Therapeutics (TPST) position steady in Q3 2014 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #1310.

BlackRock Japan first reported a position in TPST in Q3 2013 and has held it in 1 quarter since. The position peaked at $24K in Q3 2013. 53 funds tracked by Wall St. Rank hold TPST as of Q3 2014.

  • BlackRock Japan held 0 shares of Tempest Therapeutics worth $0 as of Q3 2014.
  • BlackRock Japan left its Tempest Therapeutics share count unchanged in Q3 2014.
  • Tempest Therapeutics made up ﹤0.01% of BlackRock Japan's portfolio in Q3 2014, its #1310 holding.
  • BlackRock Japan first reported a position in Tempest Therapeutics in Q3 2013 and has held it in 1 quarter since.
  • BlackRock Japan's Tempest Therapeutics position peaked at $24K in Q3 2013.
  • 53 funds tracked by Wall St. Rank held Tempest Therapeutics as of Q3 2014.

Based on BlackRock Japan's 13F filing for Q3 2014, filed 29 Oct 2014.